632
Participants
Start Date
March 15, 2024
Primary Completion Date
June 30, 2025
Study Completion Date
June 30, 2025
Xigduo (Dapagliflozin and Metformin hydrochloride extended-release) tablets
10 mg Dapagliflozin/1000 mg Metformin HCl extended-release
Dapagliflozin tablets and Metformin HCl extended-release tablets
Dapagliflozin tablets: 10 mg Metformin HCl extended-release tablets: 1000 mg
Research Site, Beijing
Research Site, Beijing
Research Site, Beijing
Research Site, Beijing
Research Site, Dalian
Research Site, Panjin
Research Site, Jiangyin
Research Site, Suzhou
Research Site, Nantong
Research Site, Hefei
Research Site, Fuyang
Research Site, Weifang
Research Site, Qingdao
Research Site, Tianjin
Research Site, Zhuji
Research Site, Wenzhou
Research Site, Rui’an
Research Site, Nanchang
Research Site, Quanzhou
Research Site, Chongqing
Research Site, Changsha
Research Site, Wuhan
Research Site, Zhengzhou
Research Site, Jiyuan
Research Site, Guangzhou
Research Site, Guangzhou
Research Site, Shenzhen
Research Site, Guiyang
Research Site, Dingzhou
Research Site, Chengdu
Research Site, Yibin
Research Site, Kunming
Research Site, Chuxiong
Research Site, Nanning
Research Site, Taiyuan
Lead Sponsor
AstraZeneca
INDUSTRY